Acumen Pharmaceuticals Net Debt Growth & History (ABOS)
Acumen Pharmaceuticals's net debt was −$22.7M for fiscal 2025.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$22.7M | −$16.8M | — |
| 2024 | 2024-12-31 | −$5.9M | $29.9M | — |
| 2023 | 2023-12-31 | −$35.8M | $94.2M | — |
| 2022 | 2022-12-31 | −$130.0M | −$7.8M | — |
| 2021 | 2021-12-31 | −$122.2M | — | — |
Acumen Pharmaceuticals quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$27.8M | −$21.1M | — |
| Q1 2026 | 2026-03-31 | −$20.6M | −$20.3M | — |
| Q4 2025 | 2025-12-31 | −$22.7M | −$16.8M | — |
| Q3 2025 | 2025-09-30 | −$16.0M | −$12.8M | — |
| Q2 2025 | 2025-06-30 | −$6.7M | $31.5M | — |
| Q1 2025 | 2025-03-31 | −$379,000 | $16.0M | — |
| Q4 2024 | 2024-12-31 | −$5.9M | $29.9M | — |
| Q3 2024 | 2024-09-30 | −$3.2M | $91.7M | — |
| Q2 2024 | 2024-06-30 | −$38.2M | $39.0M | — |
| Q1 2024 | 2024-03-31 | −$16.3M | $61.6M | — |
| Q4 2023 | 2023-12-31 | −$35.8M | $94.2M | — |
| Q3 2023 | 2023-09-30 | −$94.9M | $62.5M | — |
| Q2 2023 | 2023-06-30 | −$77.2M | $33.7M | — |
| Q1 2023 | 2023-03-31 | −$77.9M | $30.6M | — |
| Q4 2022 | 2022-12-31 | −$130.0M | −$7.8M | — |
| Q3 2022 | 2022-09-30 | −$157.4M | — | — |
| Q2 2022 | 2022-06-30 | −$110.9M | — | — |
| Q1 2022 | 2022-03-31 | −$108.6M | — | — |
| Q4 2021 | 2021-12-31 | −$122.2M | — | — |
Acumen Pharmaceuticals net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Acumen Pharmaceuticals's net debt increased from −$122.2M to −$22.7M, a change of $99.5M. The latest reported quarter, Q2 2026, shows −$27.8M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acumen Pharmaceuticals source filings ↗